Influenza Antiviral Drugs and Patent Law Issues.
Identifies and analyzes aspects of patent law affecting the availability and affordability of avian influenza antiviral medications such as the vaccine Tamiflu, produced by Roche, Inc. Examines legal options for increasing Tamiflu drug production, including the use of compulsory licensing under the...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2007.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Identifies and analyzes aspects of patent law affecting the availability and affordability of avian influenza antiviral medications such as the vaccine Tamiflu, produced by Roche, Inc. Examines legal options for increasing Tamiflu drug production, including the use of compulsory licensing under the Agreement on Trade-Related Aspects of Intellectual Property Rights and U.S. Code, and through sublicensing agreements voluntarily negotiated by Roche, Inc., with third-parties of its choosing. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |